Top

Journal of Cardiovascular Translational Research

Published in:

01-12-2013

Circulating MicroRNAs as Novel Biomarkers for the Early Diagnosis of Acute Coronary Syndrome

Authors: J. C. Deddens, J. M. Colijn, M. I. F. J. Oerlemans, G. Pasterkamp, S. A. Chamuleau, P. A. Doevendans, J. P. G. Sluijter

Published in: Journal of Cardiovascular Translational Research | Issue 6/2013

Abstract

Small non-coding microRNAs (miRNAs) are important physiological regulators of post-transcriptional gene expression. miRNAs not only reside in the cytoplasm but are also stably present in several extracellular compartments, including the circulation. For that reason, miRNAs are proposed as diagnostic biomarkers for various diseases. Early diagnosis of acute coronary syndrome (ACS), especially non-ST elevated myocardial infarction and unstable angina pectoris, is essential for optimal treatment outcome, and due to the ongoing need for additional identifiers, miRNAs are of special interest as biomarkers for ACS. This review highlights the nature and cellular release mechanisms of circulating miRNAs and therefore their potential role in the diagnosis of myocardial infarction. We will give an update of clinical studies addressing the role of circulating miRNA expression after myocardial infarction and explore the diagnostic value of this potential biomarker.

Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013). Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation, 127, e6–e245. doi:10.1161/CIR.0b013e31828124ad.PubMed

Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., & Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial. (2012). Third universal definition of myocardial infarction. European Heart Journal, 33, 2551–2567. doi:10.1093/eurheartj/ehs184.PubMed

Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Jr., Chavey, W. E., 2nd, Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2013). 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Journal of the American College of Cardiology, 61, e179–347. doi:10.1016/j.jacc.2013.01.014.PubMed

Oerlemans, M. I., Liu, J., Arslan, F., den Ouden, K., van Middelaar, B. J., Doevendans, P. A., & Sluijter, J. P. (2012). Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Research in Cardiology, 107, 270. doi:10.1007/s00395-012-0270-8.PubMed

Oerlemans, M. I., Koudstaal, S., Chamuleau, S. A., de Kleijn, D. P., Doevendans, P. A., & Sluijter, J. P. (2013). Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. International Journal of Cardiology, 165, 410–422. doi:10.1016/j.ijcard.2012.03.055.PubMed

Bodor, G. S., Porter, S., Landt, Y., & Ladenson, J. H. (1992). Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clinical Chemistry, 38, 2203–2214.PubMed

Cummins, B., Auckland, M. L., & Cummins, P. (1987). Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. American Heart Journal, 113, 1333–1344.PubMed

Hamm, C. W., Goldmann, B. U., Heeschen, C., Kreymann, G., Berger, J., & Meinertz, T. (1997). Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. The New England Journal of Medicine, 337, 1648–1653. doi:10.1056/NEJM199712043372302.PubMed

Liebetrau, C., Mollmann, H., Nef, H., Szardien, S., Rixe, J., Troidl, C., Willmer, M., Hoffmann, J., Weber, M., Rolf, A., et al. (2012). Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy. Clinical Chemistry, 58, 1049–1054. doi:10.1373/clinchem.2011.178129.PubMed

10.

Meder, B., Keller, A., Vogel, B., Haas, J., Sedaghat-Hamedani, F., Kayvanpour, E., Just, S., Borries, A., Rudloff, J., Leidinger, P., et al. (2011). MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Research in Cardiology, 106, 13–23. doi:10.1007/s00395-010-0123-2.PubMed

11.

Oerlemans, M. I., Mosterd, A., Dekker, M. S., de Vrey, E. A., van Mil, A., Pasterkamp, G., Doevendans, P. A., Hoes, A. W., & Sluijter, J. P. (2012). Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Molecular Medicine, 4, 1176–1185. doi:10.1002/emmm.201201749.PubMed

12.

Keller, T., Zeller, T., Peetz, D., Tzikas, S., Roth, A., Czyz, E., Bickel, C., Baldus, S., Warnholtz, A., Frohlich, M., et al. (2009). Sensitive troponin I assay in early diagnosis of acute myocardial infarction. The New England Journal of Medicine, 361, 868–877. doi:10.1056/NEJMoa0903515.PubMed

13.

Reiter, M., Twerenbold, R., Reichlin, T., Haaf, P., Peter, F., Meissner, J., Hochholzer, W., Stelzig, C., Freese, M., Heinisch, C., et al. (2011). Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. European Heart Journal, 32, 1379–1389. doi:10.1093/eurheartj/ehr033.PubMed

14.

de Lemos, J. A., Drazner, M. H., Omland, T., Ayers, C. R., Khera, A., Rohatgi, A., Hashim, I., Berry, J. D., Das, S. R., Morrow, D. A., et al. (2010). Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. Journal of the American Medical Association, 304, 2503–2512. doi:10.1001/jama.2010.1768.PubMed

15.

Eggers, K. M., Lind, L., Ahlstrom, H., Bjerner, T., Ebeling Barbier, C., Larsson, A., Venge, P., & Lindahl, B. (2008). Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. European Heart Journal, 29, 2252–2258. doi:10.1093/eurheartj/ehn327.PubMed

16.

Grande, P., Hansen, B. F., Christiansen, C., & Naestoft, J. (1981). Acute myocardial infarct size estimated by serum CK-MB determinations: clinical accuracy and prognostic relevance utilizing a practical modification of the isoenzyme approach. American Heart Journal, 101, 582–586.PubMed

17.

Alpert, J. S., Thygesen, K., Antman, E., & Bassand, J. P. (2000). Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology, 36, 959–969.PubMed

18.

de Winter, R. J., Koster, R. W., Sturk, A., & Sanders, G. T. (1995). Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. Circulation, 92, 3401–3407.PubMed

19.

Ishii, J., Wang, J. H., Naruse, H., Taga, S., Kinoshita, M., Kurokawa, H., Iwase, M., Kondo, T., Nomura, M., Nagamura, Y., et al. (1997). Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clinical Chemistry, 43, 1372–1378.PubMed

20.

Freund, Y., Chenevier-Gobeaux, C., Leumani, F., Claessens, Y. E., Allo, J. C., Doumenc, B., Cosson, C., Bonnet, P., Riou, B., & Ray, P. (2012). Heart-type fatty acid binding protein and the diagnosis of acute coronary syndrome in the ED. The American Journal of Emergency Medicine, 30, 1378–1384. doi:10.1016/j.ajem.2011.10.001.PubMed

21.

James, S. K., Oldgren, J., Lindback, J., Johnston, N., Siegbahn, A., & Wallentin, L. (2005). An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease. American Heart Journal, 149, 619–626. doi:10.1016/j.ahj.2004.08.026.PubMed

22.

Morita, E., Yasue, H., Yoshimura, M., Ogawa, H., Jougasaki, M., Matsumura, T., Mukoyama, M., & Nakao, K. (1993). Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation, 88, 82–91.PubMed

23.

Afzali, D., Erren, M., Pavenstadt, H. J., Vollert, J. O., Hertel, S., Waltenberger, J., Reinecke, H., & Lebiedz, P. (2013). Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes. Clinical Research in Cardiology (in press). doi:10.1007/s00392-013-0583-0.

24.

Peacock, F., Morris, D. L., Anwaruddin, S., Christenson, R. H., Collinson, P. O., Goodacre, S. W., Januzzi, J. L., Jesse, R. L., Kaski, J. C., Kontos, M. C., et al. (2006). Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. American Heart Journal, 152, 253–262. doi:10.1016/j.ahj.2005.12.024.PubMed

25.

Lindahl, B. (2013). Acute coronary syndrome—the present and future role of biomarkers. Clinical Chemistry and Laboratory Medicine, 23, 1–8. doi:10.1515/cclm-2013-0074.

26.

Tijsen, A. J., Pinto, Y. M., & Creemers, E. E. (2012). Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. American Journal of Physiology - Heart and Circulatory Physiology, 303, H1085–95. doi:10.1152/ajpheart.00191.2012.PubMed

27.

Li, C., Pei, F., Zhu, X., Duan, D. D., & Zeng, C. (2012). Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clinical Biochemistry, 45, 727–732. doi:10.1016/j.clinbiochem.2012.04.013.PubMed

28.

Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008). Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. Journal of Alzheimer's Disease, 14, 27–41.PubMed

29.

Park, N. J., Zhou, H., Elashoff, D., Henson, B. S., Kastratovic, D. A., Abemayor, E., & Wong, D. T. (2009). Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clinical Cancer Research, 15, 5473–5477. doi:10.1158/1078-0432.CCR-09-0736.PubMed

30.

Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America, 105, 10513–10518. doi:10.1073/pnas.0804549105.PubMed

31.

Zubakov, D., Boersma, A. W., Choi, Y., van Kuijk, P. F., Wiemer, E. A., & Kayser, M. (2010). MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. International Journal of Legal Medicine, 124, 217–226. doi:10.1007/s00414-009-0402-3.PubMed

32.

Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research, 18, 997–1006. doi:10.1038/cr.2008.282.PubMed

33.

Lagos-Quintana, M., Rauhut, R., Lendeckel, W., & Tuschl, T. (2001). Identification of novel genes coding for small expressed RNAs. Science, 294, 853–858. doi:10.1126/science.1064921.PubMed

34.

Lytle, J. R., Yario, T. A., & Steitz, J. A. (2007). Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proceedings of the National Academy of Sciences of the United States of America, 104, 9667–9672. doi:10.1073/pnas.0703820104.PubMed

35.

Pillai, R. S., Bhattacharyya, S. N., Artus, C. G., Zoller, T., Cougot, N., Basyuk, E., Bertrand, E., & Filipowicz, W. (2005). Inhibition of translational initiation by Let-7 microRNA in human cells. Science, 309, 1573–1576. doi:10.1126/science.1115079.PubMed

36.

Wu, L., Fan, J., & Belasco, J. G. (2006). MicroRNAs direct rapid deadenylation of mRNA. Proceedings of the National Academy of Sciences of the United States of America, 103, 4034–4039. doi:10.1073/pnas.0510928103.PubMed

37.

Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281–297.PubMed

38.

Ghildiyal, M., & Zamore, P. D. (2009). Small silencing RNAs: an expanding universe. Nature Reviews Genetics, 10, 94–108. doi:10.1038/nrg2504.PubMed

39.

Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009). Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature Cell Biology, 11, 228–234. doi:10.1038/ncb0309-228.PubMed

40.

Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature, 466, 835–840. doi:10.1038/nature09267.PubMed

41.

Sluijter, J. P., van Mil, A., van Vliet, P., Metz, C. H., Liu, J., Doevendans, P. A., & Goumans, M. J. (2010). MicroRNA-1 and −499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 859–868. doi:10.1161/ATVBAHA.109.197434.PubMed

42.

Kota, J., Chivukula, R. R., O'Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H. W., Chang, T. C., Vivekanandan, P., Torbenson, M., Clark, K. R., et al. (2009). Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell, 137, 1005–1017. doi:10.1016/j.cell.2009.04.021.PubMed

43.

Lin, C. J., Gong, H. Y., Tseng, H. C., Wang, W. L., & Wu, J. L. (2008). miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochemical and Biophysical Research Communications, 375, 315–320. doi:10.1016/j.bbrc.2008.07.154.PubMed

44.

Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 99, 15524–15529. doi:10.1073/pnas.242606799.PubMed

45.

Murakami, Y., Toyoda, H., Tanaka, M., Kuroda, M., Harada, Y., Matsuda, F., Tajima, A., Kosaka, N., Ochiya, T., & Shimotohno, K. (2011). The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One, 6, e16081. doi:10.1371/journal.pone.0016081.PubMed

46.

Chen, J. F., Murchison, E. P., Tang, R., Callis, T. E., Tatsuguchi, M., Deng, Z., Rojas, M., Hammond, S. M., Schneider, M. D., Selzman, C. H., et al. (2008). Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proceedings of the National Academy of Sciences of the United States of America, 105, 2111–2116. doi:10.1073/pnas.0710228105.PubMed

47.

Madrigal-Matute, J., Rotllan, N., Aranda, J. F., & Fernandez-Hernando, C. (2013). MicroRNAs and atherosclerosis. Current Atherosclerosis Reports, 15, 322. doi:10.1007/s11883-013-0322-z.PubMed

48.

Rayner, K. J., Suarez, Y., Davalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernandez-Hernando, C. (2010). MiR-33 contributes to the regulation of cholesterol homeostasis. Science, 328, 1570–1573. doi:10.1126/science.1189862.PubMed

49.

Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009). MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science, 324, 1710–1713. doi:10.1126/science.1174381.PubMed

50.

Tijsen, A. J., Creemers, E. E., Moerland, P. D., de Windt, L. J., van der Wal, A. C., Kok, W. E., & Pinto, Y. M. (2010). MiR423-5p as a circulating biomarker for heart failure. Circulation Research, 106, 1035–1039. doi:10.1161/CIRCRESAHA.110.218297.PubMed

51.

Hoekstra, M., van der Lans, C. A., Halvorsen, B., Gullestad, L., Kuiper, J., Aukrust, P., van Berkel, T. J., & Biessen, E. A. (2010). The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochemical and Biophysical Research Communications, 394, 792–797. doi:10.1016/j.bbrc.2010.03.075.PubMed

52.

Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834–838. doi:10.1038/nature03702.PubMed

53.

Liu, C. G., Calin, G. A., Meloon, B., Gamliel, N., Sevignani, C., Ferracin, M., Dumitru, C. D., Shimizu, M., Zupo, S., Dono, M., et al. (2004). An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proceedings of the National Academy of Sciences of the United States of America, 101, 9740–9744. doi:10.1073/pnas.0403293101.PubMed

54.

Hanke, M., Hoefig, K., Merz, H., Feller, A. C., Kausch, I., Jocham, D., Warnecke, J. M., & Sczakiel, G. (2010). A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urologic Oncology, 28, 655–661. doi:10.1016/j.urolonc.2009.01.027.PubMed

55.

Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., Hristov, M., Koppel, T., Jahantigh, M. N., Lutgens, E., et al. (2009). Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signaling, 2, ra81. doi:10.1126/scisignal.2000610.PubMed

56.

Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., & Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 9, 654–659. doi:10.1038/ncb1596.PubMed

57.

Xu, L., Yang, B. F., & Ai, J. (2013). MicroRNA transport: a new way in cell communication. Journal of Cellular Physiology, 228, 1713–1719. doi:10.1002/jcp.24344.PubMed

58.

Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America, 108, 5003–5008. doi:10.1073/pnas.1019055108.PubMed

59.

Wang, K., Zhang, S., Weber, J., Baxter, D., & Galas, D. J. (2010). Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Research, 38, 7248–7259. doi:10.1093/nar/gkq601.PubMed

60.

Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., & Remaley, A. T. (2011). MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biology, 13, 423–433. doi:10.1038/ncb2210.PubMed

61.

Wagner, J., Riwanto, M., Besler, C., Knau, A., Fichtlscherer, S., Roxe, T., Zeiher, A. M., Landmesser, U., & Dimmeler, S. (2013). Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 1392–1400. doi:10.1161/ATVBAHA.112.300741.PubMed

62.

Collino, F., Deregibus, M. C., Bruno, S., Sterpone, L., Aghemo, G., Viltono, L., Tetta, C., & Camussi, G. (2010). Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One, 5, e11803. doi:10.1371/journal.pone.0011803.PubMed

63.

El-Hefnawy, T., Raja, S., Kelly, L., Bigbee, W. L., Kirkwood, J. M., Luketich, J. D., & Godfrey, T. E. (2004). Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clinical Chemistry, 50, 564–573. doi:10.1373/clinchem.2003.028506.PubMed

64.

Guduric-Fuchs, J., O'Connor, A., Camp, B., O'Neill, C. L., Medina, R. J., & Simpson, D. A. (2012). Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics, 13, 357. doi:10.1186/1471-2164-13-357.PubMed

65.

Stoorvogel, W. (2012). Functional transfer of microRNA by exosomes. Blood, 119, 646–648. doi:10.1182/blood-2011-11-389478.PubMed

66.

Keller, S., Sanderson, M. P., Stoeck, A., & Altevogt, P. (2006). Exosomes: from biogenesis and secretion to biological function. Immunology Letters, 107, 102–108. doi:10.1016/j.imlet.2006.09.005.PubMed

67.

Thery, C. (2011). Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep, 3, 15–15. doi:10.3410/B3-15.PubMed

68.

Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., & Ochiya, T. (2010). Secretory mechanisms and intercellular transfer of microRNAs in living cells. Journal of Biological Chemistry, 285, 17442–17452. doi:10.1074/jbc.M110.107821.PubMed

69.

Savina, A., Furlan, M., Vidal, M., & Colombo, M. I. (2003). Exosome release is regulated by a calcium-dependent mechanism in K562 cells. Journal of Biological Chemistry, 278, 20083–20090. doi:10.1074/jbc.M301642200.PubMed

70.

Savina, A., Fader, C. M., Damiani, M. T., & Colombo, M. I. (2005). Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic, 6, 131–143. doi:10.1111/j.1600-0854.2004.00257.x.PubMed

71.

Kuwabara, Y., Ono, K., Horie, T., Nishi, H., Nagao, K., Kinoshita, M., Watanabe, S., Baba, O., Kojima, Y., Shizuta, S., et al. (2011). Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circulation. Cardiovascular Genetics, 4, 446–454. doi:10.1161/CIRCGENETICS.110.958975.PubMed

72.

Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215–233. doi:10.1016/j.cell.2009.01.002.PubMed

73.

Weber, C. (2013). MicroRNAs: from basic mechanisms to clinical application in cardiovascular medicine. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 168–169. doi:10.1161/ATVBAHA.112.300920.PubMed

74.

Mendell, J. T., & Olson, E. N. (2012). MicroRNAs in stress signaling and human disease. Cell, 148, 1172–1187. doi:10.1016/j.cell.2012.02.005.PubMed

75.

Fiedler, J., & Thum, T. (2013). MicroRNAs in myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 201–205. doi:10.1161/ATVBAHA.112.300137.PubMed

76.

He, L., & Hannon, G. J. (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics, 5, 522–531. doi:10.1038/nrg1379.PubMed

77.

Care, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M. L., Segnalini, P., Gu, Y., Dalton, N. D., et al. (2007). MicroRNA-133 controls cardiac hypertrophy. Nature Medicine, 13, 613–618. doi:10.1038/nm1582.PubMed

78.

D'Alessandra, Y., Devanna, P., Limana, F., Straino, S., Di Carlo, A., Brambilla, P. G., Rubino, M., Carena, M. C., Spazzafumo, L., De Simone, M., et al. (2010). Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. European Heart Journal, 31, 2765–2773. doi:10.1093/eurheartj/ehq167.PubMed

79.

Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., Weber, M., Hamm, C. W., Roxe, T., Muller-Ardogan, M., et al. (2010). Circulating microRNAs in patients with coronary artery disease. Circulation Research, 107, 677–684. doi:10.1161/CIRCRESAHA.109.215566.PubMed

80.

Fiedler, J., Jazbutyte, V., Kirchmaier, B. C., Gupta, S. K., Lorenzen, J., Hartmann, D., Galuppo, P., Kneitz, S., Pena, J. T., Sohn-Lee, C., et al. (2011). MicroRNA-24 regulates vascularity after myocardial infarction. Circulation, 124, 720–730. doi:10.1161/CIRCULATIONAHA.111.039008.PubMed

81.

Shi, B., Guo, Y., Wang, J., & Gao, W. (2010). Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction. BMC Cardiovascular Disorders, 10, 11. doi:10.1186/1471-2261-10-11.PubMed

82.

Shan, Z. X., Lin, Q. X., Fu, Y. H., Deng, C. Y., Zhou, Z. L., Zhu, J. N., Liu, X. Y., Zhang, Y. Y., Li, Y., Lin, S. G., et al. (2009). Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochemical and Biophysical Research Communications, 381, 597–601. doi:10.1016/j.bbrc.2009.02.097.PubMed

83.

Bostjancic, E., Zidar, N., & Glavac, D. (2009). MicroRNA microarray expression profiling in human myocardial infarction. Disease Markers, 27, 255–268. doi:10.3233/DMA-2009-0671.PubMed

84.

Bostjancic, E., Zidar, N., Stajer, D., & Glavac, D. (2010). MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology, 115, 163–169. doi:10.1159/000268088.PubMed

85.

Bostjancic, E., Zidar, N., Stajner, D., & Glavac, D. (2010). MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction. Folia Biol (Praha), 56, 27–31.

86.

van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008). Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proceedings of the National Academy of Sciences of the United States of America, 105, 13027–13032. doi:10.1073/pnas.0805038105.PubMed

87.

De Rosa, S., Fichtlscherer, S., Lehmann, R., Assmus, B., Dimmeler, S., & Zeiher, A. M. (2011). Transcoronary concentration gradients of circulating microRNAs. Circulation, 124, 1936–1944. doi:10.1161/CIRCULATIONAHA.111.037572.PubMed

88.

Gidlof, O., Smith, J. G., Miyazu, K., Gilje, P., Spencer, A., Blomquist, S., & Erlinge, D. (2013). Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovascular Disorders, 13, 12. doi:10.1186/1471-2261-13-12.PubMed

89.

Sluijter, J. (2013). MicroRNAs in cardiovascular regenerative medicine: directing tissue repair and cellular differentiation. ISRN Vascular Medicine, 2013, 593517.

90.

Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., & Wang, D. Z. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nature Genetics, 38, 228–233. doi:10.1038/ng1725.PubMed

91.

Kloosterman, W. P., Steiner, F. A., Berezikov, E., de Bruijn, E., van de Belt, J., Verheul, M., Cuppen, E., & Plasterk, R. H. (2006). Cloning and expression of new microRNAs from zebrafish. Nucleic Acids Research, 34, 2558–2569. doi:10.1093/nar/gkl278.PubMed

92.

van Rooij, E., Quiat, D., Johnson, B. A., Sutherland, L. B., Qi, X., Richardson, J. A., Kelm, R. J., Jr., & Olson, E. N. (2009). A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Developmental Cell, 17, 662–673. doi:10.1016/j.devcel.2009.10.013.PubMed

93.

University of Manchester, Faculty of Life Science (2012). miRBase. http://www.mirbase.org. Accessed 3 May 2013.

94.

Zhao, Y., Samal, E., & Srivastava, D. (2005). Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 436, 214–220. doi:10.1038/nature03817.PubMed

95.

Yang, B., Lin, H., Xiao, J., Lu, Y., Luo, X., Li, B., Zhang, Y., Xu, C., Bai, Y., Wang, H., et al. (2007). The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nature Medicine, 13, 486–491. doi:10.1038/nm1569.PubMed

96.

Catalucci, D., Latronico, M. V., & Condorelli, G. (2008). MicroRNAs control gene expression: importance for cardiac development and pathophysiology. Annals of the New York Academy of Sciences, 1123, 20–29. doi:10.1196/annals.1420.004.PubMed

97.

Ai, J., Zhang, R., Li, Y., Pu, J., Lu, Y., Jiao, J., Li, K., Yu, B., Li, Z., Wang, R., et al. (2010). Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochemical and Biophysical Research Communications, 391, 73–77. doi:10.1016/j.bbrc.2009.11.005.PubMed

98.

Cheng, Y., Tan, N., Yang, J., Liu, X., Cao, X., He, P., Dong, X., Qin, S., & Zhang, C. (2010). A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clinical Science (London, England), 119, 87–95. doi:10.1042/CS20090645.

99.

Corsten, M. F., Dennert, R., Jochems, S., Kuznetsova, T., Devaux, Y., Hofstra, L., Wagner, D. R., Staessen, J. A., Heymans, S., & Schroen, B. (2010). Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circulation Cardiovascular Genetics, 3, 499–506. doi:10.1161/CIRCGENETICS.110.957415.PubMed

100.

Gidlof, O., Andersson, P., van der Pals, J., Gotberg, M., & Erlinge, D. (2011). Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology, 118, 217–226. doi:10.1159/000328869.PubMed

101.

Li, Y. Q., Zhang, M. F., Wen, H. Y., Hu, C. L., Liu, R., Wei, H. Y., Ai, C. M., Wang, G., Liao, X. X., & Li, X. (2013). Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction. Clinics (São Paulo, Brazil), 68, 75–80.

102.

Long, G., Wang, F., Duan, Q., Chen, F., Yang, S., Gong, W., Wang, Y., Chen, C., & Wang, D. W. (2012). Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. International Journal of Biological Sciences, 8, 811–818. doi:10.7150/ijbs.4439.PubMed

103.

Wang, G. K., Zhu, J. Q., Zhang, J. T., Li, Q., Li, Y., He, J., Qin, Y. W., & Jing, Q. (2010). Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European Heart Journal, 31, 659–666. doi:10.1093/eurheartj/ehq013.PubMed

104.

Widera, C., Gupta, S. K., Lorenzen, J. M., Bang, C., Bauersachs, J., Bethmann, K., Kempf, T., Wollert, K. C., & Thum, T. (2011). Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. Journal of Molecular and Cellular Cardiology, 51, 872–875. doi:10.1016/j.yjmcc.2011.07.011.PubMed

105.

Zile, M. R., Mehurg, S. M., Arroyo, J. E., Stroud, R. E., DeSantis, S. M., & Spinale, F. G. (2011). Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. Circulation Cardiovascular Genetics, 4, 614–619. doi:10.1161/CIRCGENETICS.111.959841.PubMed

106.

Olivieri, F., Antonicelli, R., Lorenzi, M., D'Alessandra, Y., Lazzarini, R., Santini, G., Spazzafumo, L., Lisa, R., La Sala, L., Galeazzi, R., et al. (2013). Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. International Journal of Cardiology, 167, 531–536. doi:10.1016/j.ijcard.2012.01.075.PubMed

107.

Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A., & Enright, A. J. (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research, 34, D140–4. doi:10.1093/nar/gkj112.PubMed

108.

Torella, D., Iaconetti, C., Catalucci, D., Ellison, G. M., Leone, A., Waring, C. D., Bochicchio, A., Vicinanza, C., Aquila, I., Curcio, A., et al. (2011). MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circulation Research, 109, 880–893. doi:10.1161/CIRCRESAHA.111.240150.PubMed

109.

Wang, R., Li, N., Zhang, Y., Ran, Y., & Pu, J. (2011). Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Internal Medicine, 50, 1789–1795.PubMed

110.

Thygesen, K., Mair, J., Katus, H., Plebani, M., Venge, P., Collinson, P., Lindahl, B., Giannitsis, E., Hasin, Y., Galvani, M., et al. (2010). Recommendations for the use of cardiac troponin measurement in acute cardiac care. European Heart Journal, 31, 2197–2204. doi:10.1093/eurheartj/ehq251.PubMed

111.

van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 316, 575–579. doi:10.1126/science.1139089.PubMed

112.

Callis, T. E., Pandya, K., Seok, H. Y., Tang, R. H., Tatsuguchi, M., Huang, Z. P., Chen, J. F., Deng, Z., Gunn, B., Shumate, J., et al. (2009). MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. The Journal of Clinical Investigation, 119, 2772–2786. doi:10.1172/JCI36154.PubMed

113.

Adachi, T., Nakanishi, M., Otsuka, Y., Nishimura, K., Hirokawa, G., Goto, Y., Nonogi, H., & Iwai, N. (2010). Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clinical Chemistry, 56, 1183–1185. doi:10.1373/clinchem.2010.144121.PubMed

114.

Devaux, Y., Vausort, M., Goretti, E., Nazarov, P. V., Azuaje, F., Gilson, G., Corsten, M. F., Schroen, B., Lair, M. L., Heymans, S., et al. (2012). Use of circulating microRNAs to diagnose acute myocardial infarction. Clinical Chemistry, 58, 559–567. doi:10.1373/clinchem.2011.173823.PubMed

115.

Wang, J. X., Jiao, J. Q., Li, Q., Long, B., Wang, K., Liu, J. P., Li, Y. R., & Li, P. F. (2011). miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nature Medicine, 17, 71–78. doi:10.1038/nm.2282.PubMed

116.

Hosoda, T., Zheng, H., Cabral-da-Silva, M., Sanada, F., Ide-Iwata, N., Ogorek, B., Ferreira-Martins, J., Arranto, C., D'Amario, D., del Monte, F., et al. (2011). Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation, 123, 1287–1296. doi:10.1161/CIRCULATIONAHA.110.982918.PubMed

117.

Cacchiarelli, D., Legnini, I., Martone, J., Cazzella, V., D'Amico, A., Bertini, E., & Bozzoni, I. (2011). miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Molecular Medicine, 3, 258–265. doi:10.1002/emmm.201100133.PubMed

118.

Salic, K., & De Windt, L. J. (2012). MicroRNAs as biomarkers for myocardial infarction. Current Atherosclerosis Reports, 14, 193–200. doi:10.1007/s11883-012-0238-z.PubMed

119.

Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008). The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Developmental Cell, 15, 261–271. doi:10.1016/j.devcel.2008.07.002.PubMed

120.

Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., Lee, T. H., Miano, J. M., Ivey, K. N., & Srivastava, D. (2009). miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 460, 705–710. doi:10.1038/nature08195.PubMed

121.

Fish, J. E., Santoro, M. M., Morton, S. U., Yu, S., Yeh, R. F., Wythe, J. D., Ivey, K. N., Bruneau, B. G., Stainier, D. Y., & Srivastava, D. (2008). miR-126 regulates angiogenic signaling and vascular integrity. Developmental Cell, 15, 272–284. doi:10.1016/j.devcel.2008.07.008.PubMed

122.

Kuhnert, F., Mancuso, M. R., Hampton, J., Stankunas, K., Asano, T., Chen, C. Z., & Kuo, C. J. (2008). Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development, 135, 3989–3993. doi:10.1242/dev.029736.PubMed

123.

Zhou, J., Li, J. Y., Nguyen, P., Wang, K. C., Weiss, A., Kuo, Y. C., Chiu, J. J., Shyy, J. Y., & Chien, S. (2013). Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress. Circulation Research, 113, 40–51. doi:10.1161/CIRCRESAHA.113.280883.PubMed

124.

Konstandin, M. H., Aksoy, H., Wabnitz, G. H., Volz, C., Erbel, C., Kirchgessner, H., Giannitsis, E., Katus, H. A., Samstag, Y., & Dengler, T. J. (2009). Beta2-integrin activation on T cell subsets is an independent prognostic factor in unstable angina pectoris. Basic Research in Cardiology, 104, 341–351. doi:10.1007/s00395-008-0770-8.PubMed

125.

Gidlof, O., van der Brug, M., Ohman, J., Gilje, P., Olde, B., Wahlestedt, C., & Erlinge, D. (2013). Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood, 121, 3908–3917. doi:10.1182/blood-2012-10-461798.PubMed

126.

O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proceedings of the National Academy of Sciences of the United States of America, 104, 1604–1609. doi:10.1073/pnas.0610731104.PubMed

127.

Gironella, M., Seux, M., Xie, M. J., Cano, C., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M. L., Jeang, K. T., et al. (2007). Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proceedings of the National Academy of Sciences of the United States of America, 104, 16170–16175. doi:10.1073/pnas.0703942104.PubMed

128.

Vigorito, E., Perks, K. L., Abreu-Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S., Das, P. P., Miska, E. A., Rodriguez, A., Bradley, A., et al. (2007). MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity, 27, 847–859. doi:10.1016/j.immuni.2007.10.009.PubMed

129.

Liu, J., van Mil, A., Vrijsen, K., Zhao, J., Gao, L., Metz, C. H., Goumans, M. J., Doevendans, P. A., & Sluijter, J. P. (2011). MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. Journal of Cellular and Molecular Medicine, 15, 1474–1482. doi:10.1111/j.1582-4934.2010.01104.x.PubMed

130.

Liu, J., van Mil, A., Aguor, E. N., Siddiqi, S., Vrijsen, K., Jaksani, S., Metz, C., Zhao, J., Strijkers, G. J., Doevendans, P. A., et al. (2012). MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16. Journal of Cellular and Molecular Medicine, 16, 2379–2386. doi:10.1111/j.1582-4934.2012.01551.x.PubMed

131.

Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O., Brummelkamp, T. R., Fleming, M. D., & Camargo, F. D. (2008). Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature, 451, 1125–1129. doi:10.1038/nature06607.PubMed

132.

Oerlemans, M., van Mil, A., Liu, J., van Eeuwijk, E., den Ouden, K., Doevendans, P., & Sluijter, J. (2012). Inhibition of miR-223 reduces inflammation but not adverse cardiac remodelling after myocardial ischemia-reperfusion in vivo. Discov Biol Med, 1, 3–10.

133.

Taganov, K. D., Boldin, M. P., Chang, K. J., & Baltimore, D. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America, 103, 12481–12486. doi:10.1073/pnas.0605298103.PubMed

134.

Tatsuguchi, M., Seok, H. Y., Callis, T. E., Thomson, J. M., Chen, J. F., Newman, M., Rojas, M., Hammond, S. M., & Wang, D. Z. (2007). Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. Journal of Molecular and Cellular Cardiology, 42, 1137–1141. doi:10.1016/j.yjmcc.2007.04.004.PubMed

135.

Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 456, 980–984. doi:10.1038/nature07511.PubMed

136.

Li, C., Fang, Z., Jiang, T., Zhang, Q., Liu, C., Zhang, C., & Xiang, Y. (2013). Serum microRNAs profile from genom-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris. BMC Medical Genomics, 6, 16. doi:10.1186/1755-8794-6-16.PubMed

137.

Gupta, S., Singh, K. N., Bapat, V., Mishra, V., Agarwal, D. K., & Gupta, P. (2008). Diagnosis of acute myocardial infarction: CK-MB versus cTn-T in Indian patients. Indian Journal of Clinical Biochemistry, 23, 89–91. doi:10.1007/s12291-008-0021-7.PubMed

Title: Circulating MicroRNAs as Novel Biomarkers for the Early Diagnosis of Acute Coronary Syndrome
Authors: J. C. Deddens
J. M. Colijn
M. I. F. J. Oerlemans
G. Pasterkamp
S. A. Chamuleau
P. A. Doevendans
J. P. G. Sluijter
Publication date: 01-12-2013
Publisher: Springer US
Published in: Journal of Cardiovascular Translational Research / Issue 6/2013
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-013-9493-9

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Circulating MicroRNAs as Novel Biomarkers for the Early Diagnosis of Acute Coronary Syndrome

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2013

The Therapeutic Potential of miRNAs in Cardiac Fibrosis: Where Do We Stand?

MicroRNAs in Endothelial Senescence and Atherosclerosis

Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis

The Non-coding Road Towards Cardiac Regeneration

Transcriptional Network Analysis for the Regulation of Left Ventricular Hypertrophy and Microvascular Remodeling

Electrical Stimulation Promotes Maturation of Cardiomyocytes Derived from Human Embryonic Stem Cells

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page